Amendment 259 to recital 4
Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest
A10-0272/2025 – Tomislav Sokol – Recital 4 – Am 259
Rejected
- For
- 197
- Against
- 454
- Abstained
- 7
roll-call vote at 12:50 · 30% of votes cast in favour
Roll call requested by Patriots
How the groups voted
A group’s line is the position at least two thirds of its voting MEPs took; otherwise it is shown as Divided. Groups from left to right.
| Group | For | Against | Abstained | of | Line |
|---|---|---|---|---|---|
| The Left | 0 | 38 | 0 | 38 | Against |
| Greens | 0 | 50 | 0 | 50 | Against |
| S&D | 0 | 126 | 0 | 126 | Against |
| Renew | 2 | 67 | 0 | 69 | Against |
| EPP | 7 | 165 | 2 | 174 | Against |
| ECR | 72 | 1 | 0 | 73 | For |
| Patriots | 78 | 0 | 0 | 78 | For |
| ESN | 24 | 0 | 0 | 24 | For |
| No group | 14 | 7 | 5 | 26 | — |
“of” = MEPs of the group who voted. Groups as they are now.
Every MEP
78 MEPs of 658 Clear filters
“Votes in which an MEP voted differently from their group: on decision pages, against a line at least two thirds of the group took; in loyalty figures, against the position most of the group took.” = voted otherwise than a clear line (two thirds of its votes) of the group they sit in now. MEPs with no vote recorded are not listed.